Acorda Therapeutics, Inc. [ACOR] President & CEO to Ring The ...
Market Wire (press release) - USA
... Acorda's lead clinical-stage product is Fampridine-SR, which is in a Phase 3 clinical trial to evaluate its safety and efficacy in improving walking ability in ...